SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Percentile
P0
Near historical low
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-100.00%
2024-40.94%
2023-90.63%
2022-60.73%
202110.21%
20201504.82%
20190.00%